Millenium Biologix Corporation

Millenium Biologix Corporation is a leading biomedical company, developing and supplying innovative products for Regenerative Medicine in the field of skeletal disease and trauma, covering clinical and research markets around the world. Millenium Biologix is publicly traded on the Toronto Stock Exchange (TSX) under the symbol MBC. Millenium has R&D and production facilities in Canada and Switzerland, as well as extensive international partnerships.Founded on two revolutionary "core" technologies comprising advanced synthetic Skelite™ biomaterials and synthesized BCSP™ growth factors, Millenium's clinical market focus in Regenerative Medicine is the repair and replacement of skeletal tissues, including in vitro tissue engineering of autologous cartilage and bone.
Global commercialization is achieved through targeted corporate alliances that provide marketing, sales and distribution. In addition, Millenium has an evolving network of high quality corporate and university R&D alliances in North America and Europe that strongly support the company's extensive in-house product development programs.
Our company stands at the forefront as the convergence of biology and engineering brings about major advances in healthcare. The months and years ahead will be rich in new product introductions, as we lead the world in advanced biomedical products and turnkey tissue engineering systems and services. The complete, safe and reliable solution will be from one source: Millenium Biologix.

Contact Details: 785 Midpark Drive Kingston Ontario K7M 7G3 Canada Tel: 613-389-6565 Fax: 613-389-6625 Email: mbc@millenium-biologix.com WWW: www.MILLENIUM-BIOLOGIX.COM/

Loading...

Recent Publications by Millenium Biologix Corporation:
Synthesis and characterization of single-phase silicon-substituted alpha-tricalcium phosphate. Silicon-substituted calcium phosphate (CaP) powders with a Ca/(P+Si) ratio...	11th May, 2006	Millenium Biologix Corp., 785 Midpark Drive, Kingston, Ont., Canada K7M	Biomaterials. 2006 May;27(15):2916-25. Epub 2006 Jan 30. DOI Direct Link

Millenium Biologix Corporation Patents:
US Patent No.	Title
6846493	Synthetic biomaterial compound of calcium phosphate phases particularly adapted for supporting bone cell activity
6585992	Synthetic biomaterial compound of calcium phosphate phases particularly adapted for supporting bone cell activity
6361312	High temperature materials processing furnace
6323146	Synthetic biomaterial compound of calcium phosphate phases particularly adapted for supporting bone cell activity
5861306	Multi-well bone culture device for use in assessment of bone cell activity
→View more Millenium Biologix Corporation patents.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 2605 times since April 2007, the link to the organisation's website has been followed 664 times

Recent Search Terms used to find this page: millenium biologix | Millenium Biologix | millenium biologix corporation | millenium biologix corporation | millenium biologix company website | millenium biologix | Millenium Biologix | Millenium biologix corporation | millenium biologix | millenium biologix | .

Search for more companies in Kingston

Search for more companies in Ontario

This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Millenium Biologix Corporation